| Original language | English |
|---|---|
| Article number | e1722 |
| Number of pages | 6 |
| Journal | Clinical and Translational Medicine |
| Volume | 14 |
| Issue number | 6 |
| Online published | 20 Jun 2024 |
| DOIs | |
| Publication status | Published - Jun 2024 |
Funding
This research was funded by grants from the National Key Research and Development Program of China (2022YFC2503300) and National Natural Science Foundation of China (32241017 and 32030053), Shenzhen Medical Research Fund (SMRF B2302042), Science and Technology Commission of Shanghai Municipality (22140903300), and startup funds from the City University of Hong Kong (9380154 and 7006046), RGC Theme-based Research Scheme (8770011), and TBSC Project fund. DWY was supported by Shenzhen Clinical Research Center for Metabolic Diseases (Shenzhen Science, Technology and Innovation [2021]287), Shenzhen Center for Diabetes Control and Prevention (NO: SZMHC [2020]46).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
RGC Funding Information
- RGC-funded
Fingerprint
Dive into the research topics of 'Biomarker discovery and metabolic profiling in serum of cardiovascular disease patients with untargeted metabolomics and machine learning'. Together they form a unique fingerprint.Projects
- 1 Active
-
TBRS-Sub-pj: Single-Cell Multi-Omics Study of Atherosclerotic Vascular Disease: Narrowing the Gap Between Bench and Bedside
YIN, H. (Principal Investigator / Project Coordinator)
1/01/24 → …
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver